Characteristics baseline | Elderly LVT group (n = 144) | Younger LVT group (n = 171) | P valuea |
---|---|---|---|
Age, years | 71 (67, 76) | 54 (47, 59) | 0.001 |
Male, n (%) | 102 (70.8) | 142 (83.0) | 0.010 |
Body mass index, kg/m2 | 23.7 (20.8, 26.2) | 24.5 (22.5, 27.1) | 0.034 |
Current smoker, n (%) | 49 (34.0) | 86 (50.3) | 0.004 |
Hypertension, n (%) | 61 (42.4) | 66 (38.6) | 0.497 |
Diabetes mellitus, n (%) | 44 (30.6) | 44 (25.7) | 0.342 |
Atrial fibrillation, n (%) | 13 (9.0) | 9 (5.3) | 0.192 |
Prior SSE, n (%) | 50 (35.0) | 31 (18.1) | 0.001 |
Antiplatelet therapy | 112 (77.8) | 128 (74.9) | 0.544 |
Creatinine clearance, mL/min/1.73 m2 | 68.3 (50.7, 85.5) | 74.7 (58.5, 96.3) | 0.011 |
Triglycerides, mmol/L | 1.3(1.0-1.7) | 1.3(1.0-1.8) | 0.428 |
Cholesterol, mmol/L | 4.2(3.7–4.9) | 4.4(3.7-5.0) | 0.212 |
NT-proBNP, pg/mL | 5210 (2217.5, 10,775) | 3900 (1210, 7624) | 0.004 |
WBC, ×109/L | 7.7 (6.4, 9.9) | 8.1 (6.5, 10.9) | 0.257 |
Lymphocytes,×109/L | 1.6(1.2,2.4) | 1.7(1.3,2.5) | 0.735 |
MPV | 10.0(9.2,10.8) | 9.9(9.3,10.9) | 0.917 |
Hemoglobin, g/L | 139 (125.0, 152.8) | 146 (132.0, 157.0) | 0.983 |
D-dimer, mg/L | 1.9 (0.7, 3.0) | 1.9 (0.9, 3.0) | 0.429 |
Fibrinogen, mg/dL | 3.9 (3.1, 4.1) | 3.4 (2.9, 4.0) | 0.125 |
LV ejection fraction, % | 38.3 (29.5, 46.9) | 38.0 (28.0, 48.0) | 0.871 |
LVEDD, mm | 51.7 (47.2, 58.6) | 55.6 (48.5, 61.5) | 0.078 |
LV aneurysm, n (%) | 33 (22.9) | 34 (19.9) | 0.512 |
Area of mitral regurgitation, cm2 | 3.5 (1.7, 5.6) | 3.5 (2.0, 5.9) | 0.977 |
Thrombus size, mm2 | 265 (140.3, 421.3) | 313.0 (159.0, 485.0) | 0.144 |
Medication | Â | Â | Â |
Beta blockers, n (%) | 116 (80.6%) | 139 (81.3%) | 0.869 |
ACEI, n (%) | 96(66.7%) | 105 (61.4%) | 0.333 |
MRA, n (%) | 75(52.1%) | 81 (47.4%) | 0.404 |
Duration of follow-up | 23(10,35) | 17(10,32) | - |